Ferring Forges Fertility Pact With Chinese Academy of Sciences
Executive Summary
The Swiss firm's chief scientific officer tells Scrip that working with world-renowned researchers in Beijing can only help Ferring achieve its goal of becoming the number one reproductive medicines company.
You may also be interested in...
Ferring Plots Genomics Path With Celmatix Pact
The firms have inked a collaboration which aims to explore individual differences in women’s responses to IVF treatment, improve success rates and reduce side effects such as ovarian hyper-stimulation syndrome.
Scrip M&A Podcast: Which Companies Could Be Acquired Next?
The editorial team from Scrip discusses the M&A potential of various emerging biopharmas, such as Viking, Verona, Altimmune, Xenon and Crinetics.
Sanofi Skates To Where The Puck Is With Immunology
The French drugmaker has not abandoned oncology but has made it very clear that immunology and inflammation is the priority for its R&D euros.